Successful combination of anti-cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia
Mathias Hänel, Christian Thiede, Anett Helwig, Gabriele Prange-Krex, Jana Babatz, Michael Haack, Frank Kroschinsky, Sebastian Fetscher, Gerhard Ehninger, Martin BornhäuserVolume:
120
Year:
2003
Language:
english
Pages:
2
DOI:
10.1046/j.1365-2141.2003.04208_4.x
File:
PDF, 280 KB
english, 2003